血清肝酶与代谢综合征的相关性研究

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the association between serum liver enzymes and metabolic syndrome (MS). Methods A total of 2232 people who had physical examination in the Physical Examination Center of Qingyuan People′s Hospital were selected as study subjects from January to December 2019. They were divided into MS group and non-MS group according to whether they had MS or not. The levels of liver enzymes were compared between the two groups, the correlation of three liver enzymes with MS and its components, and their screening effect on MS were analyzed. Results There were 586 cases in the MS group and 1646 cases in the non-MS group, and the prevalence of MS in the study population was 26.25%. The liver enzyme level of MS group was higher than that of non-MS group, the difference was statistically significant (P＜0.05). In female, alanine aminotransferase (ALT) was associated with waist circumference and serum triglyceride (TG), while γ-glutamyl transferase (GGT) was associated with fasting blood glucose and TG. In male,ALT was associated with waist circumference, diastolic blood pressure and high-density lipoprotein cholesterol, while GGT was associated with waist circumference, TG and diastolic blood pressure (|r|＞0.2, P＜0.05). There was significant correlation between the MS risk and the levels of ALT and GGT in male, and GGT in female (P＜0.05). GGT could be used to screen the MS, and the possibility best critical values were respectively 15.5 U/L in female and 28.5 U/L in male. Conclusion Among the three liver enzymes, GGT has the closest relationship with MS, and GGT can better screen the possibility of MS disease.

Key words： Liver enzymes Alanine aminotransferase Aspartate aminotransferase Glutamyl transpeptidase Metabolic syndrome

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Di-yun
	CHEN Yan-hong
	TANG Jian-hui

Cite this article:

WU Di-yun,CHEN Yan-hong,TANG Jian-hui. Study on association between serum liver enzymes and metabolic syndrome[J]. 中国当代医药, 2021, 28(3): 200-203.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I3/200

[1]	Younossi Z，Tacke F，Arrese M，et al.Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J].Hepatology，2019，69（6）：2672-2682.
[2]	黄丹，贾忠萍，白雪琴，等.谷草转氨酶与代谢综合征的相关性研究[J].中国医药导报，2017，14（23）：114-117.
[5]	中华医学会内分泌学分会.非酒精性脂肪性肝病与相关代谢紊乱诊疗共识（第二版）[J].临床肝胆病杂志，2018，34（10）：2103-2108.
[10]	刘婷，王静.某医院健康体检人群血清肝脏转氨酶与代谢综合征的关联分析[J].蚌埠医学院学报，2019，44（3）：372-375.
[13]	黄秋岚，张皎月，曾天舒，等.40 岁以上人群肝酶与代谢综合征和代谢综合征前期的关系研究[J].中华内分泌代谢杂志，2015，31（10）：860-864.
[3]	Ryoo JH，Oh CM，Kim HS，et al.Clinical association between serum gamma-glutamyltransferase levels and the development of insulin resistance in Korean men：a 5-year follow-up study[J].Diabet Med，2014，31（4）：455-461.
[4]	Albeai KG，Eckel RH，Grundy SM，et al.Harmonizing the metabolic syndrome：a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention；National Heart，Lung，and Blood Institute；American Heart Association；World Heart Federation；International Atherosclerosis Society；and International Association for the Study of Obesity[J].Circulation，2009，120（16）：l640-1645．
[6]	Chalasani N，Younossi Z，Lavine JE，et al.The diagnosis and management of nonalcoholic fatty liver disease：Practice guidance from the American Association for the Study of Liver Diseases[J].Hepatology，2018，67（1）：328-357.
[7]	Mantovani A，Zaza G，Byrne CD，et al.Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease：A systematic review and meta-analysis[J].Metabolism，2018，79：64-76.
[8]	Adams LA，Anstee QM，Tilg H，et al.Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases[J].Gut，2017，66（6）：1138-1153.
[9]	Kim HR，Han MA.Association between serum liver enzymes and metabolic syndrome in korean adults[J].Int J Environ Res Public Health，2018，15（8）：1-9.
[11]	Chen S，Guo X，Yu S，et al.Metabolic syndrome and serum liver enzymes in the general Chinese population[J].Int J Environ Res Public Health，2016，13（2）：223.
[12]	He Y，Li Y，Bai G，et al.Prevalence of metabolic syndrome and individual metabolic abnormalities in China，2002-2012[J].Asia Pac J Clin Nutr，2019，28（3）：621-633.
[14]	Liu CF，Zhou WN，Lu Z，et al.The associations between liver enzymes and the risk of metabolic syndrome in the elderly[J].Exp Gerontol，2018，106：132-136.
[15]	Yadav D，Lee MY，Kim JY，et al.Combined effect of initial and longitudinal increases in gamma-glutamyltransferase on incident metabolic syndrome：ARIRANG Study[J].Yonsei Med J，2017，58（4）：763-769.
[16]	Franzini M，Fornaciari I，Rong J，et al.Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study[J].Clin Chim Acta，2013，417：19-25.
[17]	严言，孙敏，王知笑，等.40 岁以上人群肝酶与糖耐量的相关性研究[J].内科理论与实践，2012，7（4）：265-270.
[18]	Onat A，Günay C，rnek E，et al.Serum gamma-Glutamyltransferase：Independent Predictor of Risk of Diabetes，Hypertension，Metabolic Syndrome，and Coronary Disease[J].Obesity，2012，20（4）：842-848.
[19]	Shiraishi M，Tanaka M，Okada H，et al.Potential impact of the joint association of total bilirubin and gamma-glutamyltransferase with metabolic syndrome[J].Diabetol Metab Syndr，2019，11（1）：12.
[20]	Alissa EM.Relationship between serum gamma-glutamyltransferase activity and cardiometabolic risk factors in metabolic syndrome[J].J Family Med Prim Care，2018，7（2）：430-434.